DISCOUNT-ZERTIFIKAT - JOHNSON & JOHNSON Share Price

Certificat

DE000KJ0HET3

Market Closed - Deutsche Boerse AG 18:26:30 25/06/2024 BST
120.2 EUR +0.05% Intraday chart for DISCOUNT-ZERTIFIKAT - JOHNSON & JOHNSON
Current month+1.82%
1 month+1.94%
Date Price Change
25/06/24 120.2 +0.05%
24/06/24 120.2 -0.15%
21/06/24 120.4 +0.17%
20/06/24 120.1 +0.54%
19/06/24 119.5 -0.05%

Delayed Quote Deutsche Boerse AG

Last update June 25, 2024 at 06:26 pm

More quotes

Static data

Product typeDiscount Certificates
Buy / SellCALL
Underlying JOHNSON & JOHNSON
IssuerLogo Issuer Citi Citi
WKN KJ0HET
ISINDE000KJ0HET3
Date issued 06/10/2023
Maturity 05/09/2024 (72 Days)
Parity 1 : 1
Emission price 116
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 120.5
Lowest since issue 110.9

Company Profile

Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows: - pharmaceutical products (55.4%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, gastro-intestinal illnesses, infectious, immunological, neurological, dermatological diseases, etc.; - medical products and equipment (28.9%): diagnostic systems, orthopedic and gynecological equipment, surgical materials, etc. for use by healthcare professionals; - consumer health products (15.7%): OTC drugs (Tylenol, Sudafed, Benadryl, Zyrtec, Motrin, Nicorette and other brands), health and beauty products (Aveeno, Clean & Clear, Dr. CI:Labo, Neutrogena and OGX), baby care products (Johnson's and Aveeno Baby), oral care products (Listerine), feminine hygiene products (Stayfree and Carefree and o.b.), wound care products (Band-Aid and Neosporin) etc. At the end of 2022, Johnson & Johnson has 89 manufacturing facilities located in the United States (28), North America (9), Europe (27), Africa and Asia/Pacific (25). Net sales are distributed geographically as follows: the United States (51.2%), Europe (24.7%), Asia/Pacific and Africa (17.7%) and other (6.4%).
Sector
-
More about the company

Ratings for Johnson & Johnson

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Johnson & Johnson

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
23
Last Close Price
147.2 USD
Average target price
171.7 USD
Spread / Average Target
+16.66%
Consensus